arBtrage CAPITALIZING MARKETS checking… Sign in

Arvinas, Inc.

ARVN Health Care Biotechnology: Pharmaceutical Preparations
$7.42
▼ -4.1% Today
as of Jun 7, 07:09 ET
Last 30 days -27.40% Apr 28 → Jun 05
$7.15 $8.13 $9.10 $10.07 $11.05 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$7.71
High
$7.81
Low
$7.40
Volume
$631,294
Avg Vol
$2M
Mkt Cap
$570M
P/E (TTM)
Beta
52w High
$14.51
52w Low
$6.06
Div Yield
Shares Out
$64M

Overview

52-week range
$6.06
$15
16% of range
Avg surprise (last 2)
+118.9%
Avg reaction (last 2)
-12.9%
0% positive
Latest IV / EM
109%
EM ±15.2% · $7 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.25$-0.65$-0.06$0.54$1.14 Actual $-1.25Actual $-1.18Actual $-0.97Actual $-0.49Actual $-0.68Actual $1.14Est $-0.86Actual $-0.84Actual $-0.48Actual $-0.90Est $-0.95 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-61M$4M$69M$133M$198M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.90 $-0.95 +5.3% -178.9% -0.9% earnings
Tue Sep 30, 2025Sep 2025 $-0.48 financials
Mon Jun 30, 2025Jun 2025 $-0.84 financials
Thu May 1, 2025Mar/2025 $1.14 $-0.86 +232.6% -24.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.68 financials
Sun Jun 30, 2024Jun 2024 $-0.49 financials
Sun Mar 31, 2024Mar 2024 $-0.97 financials
Sat Sep 30, 2023Sep 2023 $-1.18 financials
Fri Jun 30, 2023Jun 2023 $-1.25 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$42M$22M$189M$102M$76M
Cost of revenue
Gross profit
Operating income$-64M$-44M$-72M$71M$-60M$-48M
Net income$-58M$-35M$-61M$83M$-49M$-35M
EPS (diluted)$-0.90$-0.48$-0.84$1.14$-0.68$-0.49

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$87M$143M$102M$115M$81M$100M$85M$155M
Inventory
Total current assets$631M$701M$826M$890M$980M$1.07B$1.15B$1.26B
Total assets$648M$718M$844M$909M$1.00B$1.09B$1.17B$1.28B
Long-term debt$300,000$400,000$400,000$500,000$500,000$600,000$600,000$700,000
Total liabilities$261M$284M$280M$300M$341M$530M$581M$679M
Total equity$387M$434M$564M$609M$660M$562M$586M$600M

Implied volatility — last 90 days

104%106%109%111%114% Jun 07 — IV 109% · EM ±15.2%

Sector peers